Evidence map›Paper›PMID 24507716›Full record

ArticleMolecular cell2014

Arginine methylation facilitates the recruitment of TOP3B to chromatin to prevent R loop accumulation.

Yanzhong Yang, Kevin M McBride, Sean Hensley, Yue Lu, Frederic Chedin, Mark T Bedford

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 172 papers.

0numbers the graph read from it
0cells of the map it votes in
172citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

172 citing papers in PubMed, 256 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. The Roles of Topoisomerases in Transcriptional Regulation.International journal of molecular sciences · 2026
    Review
  8. Article
  9. Current aging science · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Topoisomerase IIIβ protects from tumorigenesis and immune dysregulation.bioRxiv : the preprint server for biology · 2025
    Article

112 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yanzhong YangThe University of Texas MD Anderson Cancer Center, P.O. Box 389, Smithville, TX 78957, USA.
Kevin M McBrideThe University of Texas MD Anderson Cancer Center, P.O. Box 389, Smithville, TX 78957, USA.
Sean HensleyThe University of Texas MD Anderson Cancer Center, P.O. Box 389, Smithville, TX 78957, USA.
Yue LuThe University of Texas MD Anderson Cancer Center, P.O. Box 389, Smithville, TX 78957, USA.
Frederic ChedinDepartment of Molecular & Cellular Biology, The University of California at Davis, Davis, CA 95616, USA.
Mark T BedfordThe University of Texas MD Anderson Cancer Center, P.O. Box 389, Smithville, TX 78957, USA. Electronic address: mtbedford@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USUniversity of California, Davis · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
University of Texas M.D. Anderson Cancer SPORE-LeukemiaP50CA100632 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KONOPLEVA, MARINA Y · 2003 to 2023
$43.7M
The Functional Analysis of the Coactivator CARM1R01DK062248 · NIDDK · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BEDFORD, MARK T. · 2002 to 2015
$4.2M
"R-loop formation protects CpG islands against epigenetic silencing".R01GM094299 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHEDIN, FREDERIC LOUIS · 2010 to 2015
$1.5M
The Functional Analysis of the Coactivator CARM1R56DK062248 · NIDDK · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BEDFORD, MARK T · 2007 to 2007
$77k
NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA100632NIDDK NIH HHS DK062248NIDDK NIH HHS R01 DK062248NIDDK NIH HHS R56 DK062248NIGMS NIH HHS GM094299NIGMS NIH HHS R01 GM094299
6 · The paper itself

Abstract

Tudor domain-containing protein 3 (TDRD3) is a major methylarginine effector molecule that reads methyl-histone marks and facilitates gene transcription. However, the underlying mechanism by which TDRD3 functions as a transcriptional coactivator is unknown. We identified topoisomerase IIIB (TOP3B) as a component of the TDRD3 complex. TDRD3 serves as a molecular bridge between TOP3B and arginine-methylated histones. The TDRD3-TOP3B complex is recruited to the c-MYC gene promoter primarily by the H4R3me2a mark, and the complex promotes c-MYC gene expression. TOP3B relaxes negative supercoiled DNA and reduces transcription-generated R loops in vitro. TDRD3 knockdown in cells increases R loop formation at the c-MYC locus, and Tdrd3 null mice exhibit elevated R loop formation at this locus in B cells. Tdrd3 null mice show significantly increased c-Myc/Igh translocation, a process driven by R loop structures. By reducing negative supercoiling and resolving R loops, TOP3B promotes transcription, protects against DNA damage, and reduces the frequency of chromosomal translocations.

Indexed as

AnimalsArginineChromatinDNA Topoisomerases, Type IGene Expression RegulationGenomic InstabilityHEK293 CellsHumansMethylationMiceMice, KnockoutProteinsProtein TransportProto-Oncogene Proteins c-mycTranscription, GeneticArginineChromatinDNA Topoisomerases, Type IMYC protein, humanProteinsProto-Oncogene Proteins c-mycTdrd3 protein, humantdrd3 protein, mouse

Identifiers

PMID24507716
PMCPMC3959860
OpenAlexW1990347983

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.